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Abstract
Background
Patient adherence to prescribed antiretroviral  medication  is  crucial  to  achieve  optimum  results
from Human Immunodeficiency Virus (HIV) treatment. Poor adherence leads to treatment  failure
with many studies observing that numerous factors impact negatively or  positively  on  adherence
to antiretroviral treatment (ART).  
Objectives
This study aims to systematically review the literature of factors affecting adherence to ART in
Asian developing countries.
Methods
Database searches were  conducted  in  Medline/Ovid,  Cochrane  library,  CINAHL,  Scopus  and
PsychINFO  for  studies  published  between  1996  and  December  2010.  The  reference  lists  of
included papers were also checked, with citation searching on key papers.
Results
A total of 437 studies were identified, and 18 articles met the inclusion criteria and were extracted
and critically appraised, representing in 12 quantitative, four qualitative  and  two  mixed-methods
studies. Thirty-one individual themes, including financial difficulties, side-effects,  access,  stigma
and discrimination, simply forgetting, and being too busy had a negative impact  on  adherence  to
ART, and 11 themes,  including  family  support,  self-efficacy,  and  desire  to  live  longer  had  a
positive impact.
Conclusion
Adherence to ART is a  dynamic  phenomenon  which  varies  between  individuals.  We  need  to
address the negatively impacting factors while positively impacting factors should be promoted to
the wider population.  Policy  makers  should  develop  targeted  interventions,  such  as,  financial
support, better access points for refill  medicine  and  consulting  doctors  for  support  with   side-
effects, social support, warm and caring relationships with care providers to promote and reinforce
adherence.
Background
Antiretroviral treatment (ART) aims to provide relief to HIV-infected individuals by reducing  the
likelihood of opportunistic infections rather than curing the disease.  Since  1996  the  introduction
of ART has significantly improved the life span and quality  of  life  for  people  living  with  HIV
(PLWH) (Amico et al., 2005). Better  ART  has  led  to  a  reduction  in  disease  progression,  but
around 25% of new HIV  cases  are  regimen  resistant  (DoH,  2001).  Hence,  HIV  is  still  a  life
threatening and lifelong infection.
Medication adherence is  a crucial component for successful treatment  as  it  has  been  associated
with clinically significant viral load reduction (Lopez et al., 2007). However, maintaining optimal
levels of adherence over a lifetime is difficult (Cooper et al., 2009). Obtaining the full  benefits  of
ART is a complex individual behavioural process determined by many  broader  factors  including
patient attributes and health care systems. Human behaviours and beliefs,   inadequate  knowledge
and negative attitudes toward ART, drug side-effects, financial constraints, service-related factors,
stigma,  discrimination,  inability  to   disclose   HIV   status   and   various   socio-cultural   issues
[pic](Nordqvist et al., 2006, Kgatlwane et al.,  2005,  Mills  et  al.,  2006b,  Sanjobo  et  al.,  2009,
Hendershot et al., 2009, Murray et al., 2009) may be  significant  impacting  factors  that  prevents
patients from seeking treatment as well as maintaining adherence.  Although  there was “a paucity
of data to guide the implementation of adherence intervention in clinical settings”  (Simoni  et  al.,
2006). Systematic reviews  on   aspects  of  adherence  to  ART  have  been  conducted  elsewhere
[pic](Simoni et al., 2006, Mills et al., 2006a, Falagas et al., 2008, DiMatteo, 2004,  Hendershot  et
al., 2009, Malta et al., 2008, Mills et  al.,  2006b);  however,  there  appears  to  be  no  systematic
review on factors impacting on adherence to ART in Asian developing  countries.  Therefore,  this
review of published articles on factors  impacting  on  adherence  to  ART  could  have  significant
value in Asia  as well as providing  information  for  wider  populations  in  order  to  achieve  full
benefits for ART patients and service providers.
Aims
The main aim is to systematically review the literature on factors impacting on adherence to ART
in Asian developing countries.
Methods
This review considered qualitative, quantitative and mixed-method studies  that  examined  factors
impacting on adherence of ART for PLWH.  Combining quantitative and qualitative  studies  in  a
systematic review may provide additional insights into links between theory and practice  (Dixon-
Woods  et  al.,  2005).  Qualitative  research  may  provide  detailed  information  on   delivery   of
interventions, which  is  not  the  focus  of  quantitative  studies.  Therefore,  this  review  included
qualitative data from individual interviews and focus group discussions together with  quantitative
survey data. It has been argued that including both qualitative and quantitative studies in a  review
may limit bias, improve reliability and enhance accuracy of recommendations (Mulrow, 1994).
Inclusion and exclusion criteria
The population consisted of participants over the age of 18 years who had  been  prescribed  ART.
Similarly, data describing ART service providers were also included to provide a staff perspective
regarding factors impacting on adherence to ART.  The  included  studies  considered  populations
from 24 Asian developing countries as defined by the World Bank  (WorldBank.,  2010)  .  Papers
where the language was not English, published before  1996,  review  articles,  policy  documents,
and adherence training manuals were excluded.
Search and selection methods
A systematic search  of  articles  that  focused  on  factors  impacting  on  adherence  to  ART  was
undertaken in relevant databases. Searches were based  only  in  English  because  of  problems  of
analysing  other  languages.  The  following  electronic  databases  were  searched:  Medline/Ovid,
Cochrane library, CINAHL, Scopus, PyschINFO between  1996  to  December  2010.  The  search
strategy combined the following key  words:  HIV  or  AIDS,  antiretroviral  or  HAART  or  ARV,
adherence or compliance, factor* or  determin*  or  barrier*,  facilitate*  or  motivate*,  Asia.  In
addition to the database searching, reference lists of  included  papers  were  checked  and  citation
searching was carried out on key papers.
Study selection and data extraction
Two authors independently reviewed the retrieved studies at title and abstract level. Those articles
meeting the inclusion criteria were critically appraised. A standard data extraction form  was  used
which covered both quantitative and qualitative research. The data extraction form was  developed
using the Centre for Reviews and Dissemination  guidance  template  (CRD,  2009).  Standardised
data  extraction  forms  provide  consistency  of  results  that  reduce  bias,  improve  validity   and
reliability. This form records  basic  information  first  (authors,  date,  title  of  paper  and  journal
details), then detailed information about each  study  (study  design,  study  location,  aims  of  the
study,  study  population,  sample  size  and  major  findings)   and   reviewers’   comments.   Data
extraction was double-checked and, if necessary, amendments were made after discussion.
Quality appraisal and data synthesis
Included studies  were  assessed  for  quality  and  relevancy  to  understanding  the  strengths  and
weaknesses  of  the  body  of  evidence  (Pawson,  2008,  CRD,  2009).   Quality  assessment   was
undertaken following Hawker and colleagues, since their tool is validated for both qualitative  and
quantitative  methods  systematic  review  in  health  care  settings  (Hawker  et  al.,   2002).   This
checklist consists of nine questions each with four subcategories (good, fair, poor  and  very  poor)
of methodological  quality  that  ranges  from  nine  (very  poor)  to  36  (good).  All  articles  were
assessed to be of good methodological quality with scores ranging from  22  to  34.  The  included
studies were read several times and findings were coded and organized in a tabulation  form.   Due
to the heterogeneity of the data (quantitative and qualitative), meta-analysis  was  not  appropriate.
Therefore, a thematic synthesis was undertaken (Harden and Thomas, 2005) and the  results  were
presented in table format (Dixon-Woods et al., 2005). 
Results
Figure 1 shows that 12 articles were  selected  from  the  database  search  and  six  emerged  from
reference lists. All studies were conducted between 2005 and 2009. Papers were  excluded  on  the
grounds of not covering Asian developing countries, wrong age range, non-English  language  and
addressing effectiveness of treatment rather than  adherence.  Thirteen  studies  were  quantitative,
four were qualitative and two mixed methods.  The sample size of the studies  ranged  from  27  to
1,366. Ten of the 18 studies were from India [pic](Akhila  et  al.,  2010,  Cauldbeck  et  al.,  2009,
Kumarasamy et al., 2005, Sarna et al., 2008, Shah et al., 2007, Sharma et al., 2007, Sogarwal  and
Bachani, 2009, Wanchu et al., 2007, Venkatesh et al., 2010, Safren et al., 2005), four from  China
[pic](Sabin et al., 2008, Starks et al., 2008, Wang et al., 2008b,  Wang  et  al.,  2009),  three  from
Thailand [pic](Li et al., 2010, Ruanjahn et al., 2010, Han et al.,  2009),  and  one  from  Cambodia
[pic](Spire et al., 2008b) (Table I). The 18  studies  identified  factors  impacting  (negatively  and
positively) on adherence (see Appendix I and II).
Figure 1: Review of studies for inclusion [pic]
  Table I: Basic characteristics of the study
|Author/year |Study      |Location & |Study design|Sample size &     |Mode of information |Outcome measured     |
|            |conducted  |setting    |            |sampling methods  |collection          |                     |
|            |year       |           |            |                  |                    |                     |
|Akhila et   | 2006- 2007|India/     |Quantitative|313/  (sampling   |Not clear           |Factors affect the   |
|al. 2010    |           |hospital   |/           |procedure unclear)|                    |patient’s adherence  |
|            |           |           |survey      |                  |                    |to HAART             |
|Cauldbeck   |2006       |India/     |Quantitative|60/ (sampling     |Self-administered   |Assess the adherence |
|et al. 2009 |           |hospital   |/           |procedure unclear)|anonymous           |to ART               |
|            |           |           |survey      |                  |questionnaire survey|                     |
|Han et al.  |2009       |Thailand/  |Qualitative/|27/purposive      |In-depth interview  |Identify factors     |
|2009        |           |hospital   |in-depth    |convenience       |                    |which facilitate or  |
|            |           |           |interview   |sampling          |                    |constrain on ART     |
|            |           |           |            |                  |                    |taking               |
|Kumarasamy  |Not stated |India/     |Qualitative |60 (sampling      |Semi structured     |Assess the barriers  |
|et al. 2005 |           |private ARV|            |procedure unclear)|in-depth interview  |and facilitators on  |
|            |           |treatment  |            |                  |                    |adherence to ART     |
|            |           |centre     |            |                  |                    |                     |
|Li et al.   |2007       |Thailand/  |Quantitative|507/ ARV (sampling|Interview with      |Examine the barriers |
|2010        |           |hospital   |/           |procedure unclear)|structured          |that lead to         |
|            |           |           |survey      |                  |questionnaire       |non-adherence        |
|Ruanjaha et |2006       |Thailand/  |Mixed       |32/ purposive or  |Pre-tested self     |Assess the factors   |
|al. 2010    |           |home/      |approach    |judgmental        |reported adherence  |impeding adherence on|
|            |           |clinic     |            |sampling          |survey and semi     |ART                  |
|            |           |           |            |                  |structured interview|                     |
|Sabin et al.|2005 - 2006|China/     |Qualitative |36 (sampling      |Semi structured     |Assess barriers faced|
|2008        |           |hospital   |            |procedure unclear)|in-depth interview  |to ART adherence     |
|            |           |           |            |                  |and FGD             |                     |
|Safren et   |Not stated |India/     |Quantitative|304 (sampling     |Self –reported      |Examine non-adherence|
|al. 2005    |           |clinic     |/           |procedure unclear)|questionnaire       |of ART and associate |
|            |           |           |Survey      |                  |                    |with any variables   |
|Sarna et al.|2004       |India/     |Quantitative|310 /(sampling    |Semi-structured     |Explore the factors  |
|2008        |           |health     |/           |procedure unclear)|interview with      |associated with      |
|            |           |facilities |survey      |                  |pre-tested          |adherence            |
|            |           |           |            |                  |questionnaire       |                     |
|Shah et al. |2004 –2005 |India/ 3   |Quantitative|279/ convenience  |Structured interview|Assess the           |
|2007        |           |private    |/           |sampling          |with pre-tested     |antiretroviral       |
|            |           |outpatients|survey      |                  |questionnaire       |adherence            |
|            |           |clinics    |            |                  |                    |                     |
|Sharma et   |November   |India/     |Mixed       |226/ purposive    |Semi structure      |Explore adherence,   |
|al. 2007    |2004 –2005 |hospital   |approach    |sampling (snow    |questionnaire       |access and impact    |
|            |           |           |            |ball sampling)    |survey/ interview   |amongst those who use|
|            |           |           |            |                  |                    |ART                  |
|Sogarwal &  |2007       |India/     |Quantitative|1366 / (sampling  |Face to face        |Assess the           |
|Bachani 2009|           |27 ARV     |/           |procedure unclear)|interview           |antiretroviral       |
|            |           |centres    |survey      |                  |                    |treatment reasons for|
|            |           |           |            |                  |                    |non-adherence        |
|Spire et al.|  2004     |Cambodia/  |Quantitative|346 (sampling     |Individual face to  |Estimate the         |
|2008        |–2005      |hospital   |/           |procedure unclear)|face pretested      |prevalence of        |
|            |           |           |survey      |                  |standardizes        |non-adherence  and   |
|            |           |           |            |                  |questionnaire       |identify the factors |
|            |           |           |            |                  |interview           |                     |
|Starks et   |Not stated |China/     |Qualitative/|29/ (sampling     |Semi structured     |Explore barriers to  |
|al. 2008    |           |hospital   |            |procedure unclear)|in-depth interview  |and facilitators of  |
|            |           |           |in-depth    |                  |                    |antiretroviral       |
|            |           |           |interview   |                  |                    |adherence            |
|Wanchu et   |2004 –2005 |India/     |Quantitative|200/(sampling     |Self-reported       |Determine adherence  |
|al. 2007    |           |clinic     |/           |procedure unclear)|questionnaire survey|and reasons for      |
|            |           |           |survey      |                  |                    |missing medications  |
|Wang et al. |2006       |China/ 7   |Quantitative|308 (sampling     |Structured face to  |Assess the reasons   |
|2008        |           |ART centres|/           |procedure unclear)|face survey         |for non-adherence    |
|            |           |           |survey      |                  |                    |                     |
|Wang & Wu   |2005       |China/     |Quantitative|181/ (sampling    |Interviewer         |Assess the levels of |
|2007        |           |rural areas|/           |procedure unclear)|administered        |adherence and        |
|            |           |           |Survey      |                  |pre-tested          |determine the factors|
|            |           |           |            |                  |questionnaire       |associated with      |
|            |           |           |            |                  |                    |suboptimal adherence |
|Venkatesh   |Not stated |India/     |Quantitative|198/ (sampling    |Structured          |Examine variables    |
|et. al 2010 |           |clinic     |/           |procedure unclear)|interviewer         |associated with ART  |
|            |           |           |survey      |                  |administered        |non-adherence        |
|            |           |           |            |                  |questionnaire       |                     |
Factors impacting on adherence to ART
Twenty-two  individual  themes  regarding  factors   impacting   negatively   on   adherence   were
identified from the 18 studies,  encompassing  patient-related  factors,  socio-cultural  factors,  and
beliefs about medication, financial, health-system and drugs-related factors (see Appendix I).
Patient-related factors: Eighteen studies  described  individual  factors  impacting  on  adherence
encompassing personal trust, beliefs, and motivation to  take  pills.  Individual  factors  relating  to
non-adherence to treatment were: forgetting to take medication on time (8 studies) [pic](Li  et  al.,
2010, Cauldbeck et al., 2009, Sarna  et  al.,  2008,  Wanchu  et  al.,  2007,  Wang  and  Wu,  2007,
Shah et al., 2007, Wang et al., 2008a, Starks et al.,  2008),  being  too  busy  with  other  things  (7
studies) [pic](Shah et al., 2007, Wang and Wu, 2007, Sarna et al., 2008, Li et al.,  2010,  Wang  et
al., 2008b, Han et al., 2009, Safren et al., 2005), being away from home (6 studies) [pic](Safren et
al., 2005, Sarna et al., 2008, Wanchu et al., 2007, Shah et al., 2007, Wang et al., 2008a,  Starks  et
al., 2008), not understanding treatment (5 studies) [pic](Han et  al.,  2009,  Wanchu  et  al.,  2007,
Wang et al., 2008a, Starks et al., 2008,  Li  et  al.,  2010),  feeling  depressed  or  overwhelmed  (5
studies) [pic](Safren et al., 2005,  Sarna  et  al.,  2008,  Sabin  et  al.,  2008,  Akhila  et  al.,  2010,
Sogarwal and Bachani, 2009), concurrent substance misuse (including alcohol & drug,  4  studies)
[pic](Safren et al.,  2005,  Wang  et  al.,  2008a,  Venkatesh  et  al.,  2010,  Sharma  et  al.,  2007),
wanting to be pills free (2 studies) [pic](Wang et al., 2008a,  Starks  et  al.,  2008).    Furthermore,
one study each identified sleeping in (Wang and Wu,  2007),  lack  of  motivation  (Akhila  et  al.,
2010),  stopping  pills  after  feeling  better  [pic](Starks  et   al.,   2008),   involvement   in   socio-
community activities (Wang and Wu, 2007) and personal problem at home (Safren et al., 2005) .
Socio-cultural factors: Factors having a negative impact on adherence to ART were:  stigma  and
discrimination, fear of being recognized, fear of disclosure of  status  to  community,  and  fear  of
stigma from family (7 studies) [pic](Wang and Wu, 2007, Wang et al., 2008b, Akhila et al., 2010,
Sabin et al., 2008, Starks et al., 2008, Kumarasamy et  al.,  2005,  Li  et  al.,  2010).   This  review
shows that to prevent unwanted disclosure, participants hid their medications which in turn  led  to
either delayed or missed medications. Similarly, four studies reported that lack  of  family  support
led to non-adherence [pic](Wang et al., 2008b,  Akhila  et  al.,  2010,  Kumarasamy  et  al.,  2005,
Wanchu et al., 2007).
Beliefs about medication: Two studies reported  that  patients  did  not  think  pills  were  needed
[pic](Wang et al., 2008b, Starks et al., 2008), one that pills were a burden (Wang  and  Wu,  2007)
and one that taking pills over a long period could lead to non-adherence (Venkatesh et al., 2010).
Financial   factors:   Thirteen   studies   reported   non-adherence   due   to   financial   difficulties
[pic](Cauldbeck et al., 2009, Sarna et al., 2008, Akhila et al., 2010, Han et  al.,  2009,  Wang  and
Wu, 2007, Sharma et al., 2007, Kumarasamy et  al.,  2005,  Ruanjahn  et  al.,  2010,  Spire  et  al.,
2008b, Safren et al., 2005, Sogarwal and Bachani, 2009, Sabin et al., 2008,  Starks  et  al.,  2008).
Transport, prescription charges, food costs and hospital diagnostic costs, were  also  prominent  as
reasons for patients failing to access their medication.
Health-system  factors:  This  included  accessibility  of  services  and  the  relationship  between
service providers. Some health care delivery systems made it difficult  to  seek  regular  treatment.
Eight studies reported that  distance from home to  health  services  caused  problems  with  access
[pic](Starks et al., 2008, Sarna et al., 2008, Li et al., 2010,  Wang  and  Wu,  2007,  Sogarwal  and
Bachani, 2009, Sharma et al., 2007, Wanchu et al., 2007, Cauldbeck et al., 2009) and two  studies
found that inadequate counselling services (limited instruction provided) [pic](Starks et al.,  2008,
Wang and Wu, 2007) prevented adherence.
Drug-related factors: Ten studies reported that drug side-effects  were  an  important  reason  for
non-adherence [pic](Sarna et al., 2008, Wang and Wu, 2007, Sharma et al., 2007, Li et  al.,  2010,
Kumarasamy et al., 2005, Ruanjahn et al., 2010, Spire et al., 2008b, Safren et  al.,  2005,  Shah  et
al.,  2007,  Wanchu  et  al.,  2007).  Whilst  two  studies  reported  that  the   complexities   of   the
medication  regimens  [pic](Wang  and  Wu,  2007,  Ruanjahn  et  al.,  2010)  had  an   impact   on
adherence to ART.  
Factors positively impacting on adherence
Eleven themes were identified from the 18 studies as factors impacting  positively  (facilitators  or
motivators) on adherence to ART (Appendix III). Among them, four studies mentioned that social
support [pic](Ruanjahn et al., 2010, Kumarasamy et al., 2005, Starks et  al.,  2008,  Akhila  et  al.,
2010),  predominantly  partners,  children  and  friends  played  a  significant   role   in   increasing
adherence. Similarly,  three  studies  reported  that  self-efficacy  [pic](Kumarasamy  et  al.,  2005,
Starks et al., 2008, Akhila et al., 2010) and willingness  to  live  longer  [pic](Kumarasamy  et  al.,
2005, Starks et al., 2008, Ruanjahn et  al.,  2010)  positively  influenced  adherence.  Two  studies
noted that improved overall health [pic](Kumarasamy et  al.,  2005,  Starks  et  al.,  2008),  getting
financial assistance [pic](Kumarasamy et al., 2005, Ruanjahn  et  al.,  2010)  and  being  in  higher
income groups [pic](Ruanjahn et al., 2010, Li et al., 2010) resulted in better adherence. Moreover,
the  use  of  electronic  reminders  [pic](Starks   et   al.,   2008),   obligation   to   live   for   family
[pic](Starks et al., 2008), good relationship with care providers  [pic](Starks  et  al.,  2008),  status
disclosure [pic](Spire et al., 2008a) and worries regarding a fear of drug resistance [pic](Starks  et
al., 2008) were found to have a positive influence on adherence.
Discussion
In  this  review,  findings  of  a  mixture  of  studies  on  adherence  to   ART   were   analysed   for
experiences of patients  who  are  prescribed  ART  and  health  service  providers  underlying  the
factors impacting on adherence. This review integrated results of both quantitative and  qualitative
studies reporting views of patients and healthcare providers and found that adherence is a dynamic
phenomenon, but ART is also a lifelong commitment for  PLWH  and  for  maximum  benefits  of
ART, adherence should be a priority.
The review revealed that individual personal factors such as simply forgetting, being too busy or depressed
 and substance misuse were common reasons impacting on non-adherence  [pic](Wang  et  al.,  2008b,
Wang et al., 2009, Starks et al., 2008, Sabin et al., 2008, Sogarwal  and  Bachani,  2009,  Sarna  et
al.,  2008,  Sharma  et  al.,  2007,  Shah  et  al.,  2007,  Li  et  al.,  2010,   Wanchu   et   al.,   2007,
Venkatesh et al., 2010, Cauldbeck et al., 2009, Kumarasamy et al., 2005). Regular patient follow-
up and health carers giving  attention  during  follow-up  might  help  improve  adherence.  Patient
specific and appropriate information and counselling may lead to  better  knowledge  and,  in  turn
can help to promote adherence. Asking individual patients to describe their  daily  behaviour  may
be helpful and care providers  could  repeat  instructions  during  follow-up  appointments.  Health
care  providers  should  provide  personal  support  (reminders)  or  directly  observe  treatment  to
improve  adherence  rates.  At  the  same  time,  substance  misuse  was   a   determinant   of   non-
adherence. There is a need for  those  patients  with  concurrent  substance  misuse  to  have  direct
observed  therapy.   Patients  who  are  depressed  could  be  advised   to   undergo   psychological
treatment before initiating ART. Patients’ self-efficacy, their  desire  to  live  longer  and  improve
their overall health due to ART were all  positive  influence  on  adherence  [pic](Ruanjahn  et  al.,
2010, Starks et al., 2008,  Akhila  et  al.,  2010,  Kumarasamy  et  al.,  2005).  This  indicates  that
individual perceptions of ART effectiveness or visible signs that medications work are  helpful  to
reinforce continuing adherence practices (Adam et al., 2003).
Similarly, complexity of regimens such as fitting the regimens into daily life, and experience of  side-
effects  were  seen  as  important  reasons  for  non-adherence  in  this  review.   ART  drugs   have
toxicities and adverse side-effects (varying from mild to severe  and  from  acute  to  chronic)  can
prevent adherence [pic](Catz et al., 2000). One study reported  that  92%  of  its  study  population
were non-adherent due to the  ART  side-effects  (Altice  et  al.,  2001).  According  to  Wilson  et
al. illness ideology (representing someone’s  belief  about  treatment)  was  described  as  a  factor
influencing adherence choices based on either trust or  distrust  (Wilson  et  al.,  2002).  Similarly,
the primary reason for medication discontinuation often was  regimen  intolerance  (Melbourne  et
al., 1998). This suggests the importance of providing educational or  counselling  interventions  as
well as  instructions on how to cope with these side-effects  (Lewis  et  al.,  2006).  Trust  in  ART
medication, self-awareness of their health, and knowledge of the consequences  of  adherence  and
non-adherence are an important basis of both trust, and belief that can reinforce adherence  despite
ART side-effects. It is worth noting that the included papers are from  narrow  time  span  (2004  -
2009), during this time there was no significant variation in available regimens and  patients  were
mostly prescribed first line ART.
Many studies identified financial difficulties (cost) as a factor  affecting  non-adherence.   Two-thirds  of  the
studies (n=12) stated that due to financial difficulties  patients  failed  to  adhere  to  their  medication.
Studies in other resource-limited settings also  concluded  that  ART  associated  costs  acted  as  a
barrier to adherence to ART [pic](Tuller et  al.,  2009,  Konkle-Parker  et  al.,  2008,  Mills  et  al.,
2006c, Naik et al., 2009, Bartlett and Shao,  2009).   Having  a  higher  income  and  better  access
points for repeat prescriptions as well as obtaining financial support or  support  with  travel  costs
generally improves adherence. [pic](Li et al., 2010, Kumarasamy  et  al.,  2005,  Ruanjahn  et  al.,
2010). Addressing the issue of non-adherence in Asian developing countries may therefore require
a somewhat different approach to solutions applied in developed countries where  financial  issues
are  not  such  a  major  concern.  The  countries  included  in  this  study  varied  in  the  range   of
governmental  and  non-governmental  support  available  for  ART   treatment.   This   will   have
impacted on issues of adherence.
This review shows that patients were embarrassed to take  medication  in  front  of  others  and  concerned
about  their  privacy  when  collecting  repeat  prescriptions;  these   worries   inhibited   adherence.
Patients who had not disclosed their HIV status, did not have support, or were  unable  to  disclose
their  status  to  others  were   more   likely   to   be   non-adherent   [pic](Wang   and   Wu,   2007,
Kumarasamy et al., 2005, Rao et al., 2007, Ferguson et al., 2002).  It was described  in  one  study
that PLWHs were unwilling to seek treatment at the nearest health institution  because  of  fear  of
stigmatization (Adeneye et al., 2006). Negative community  myths  and  beliefs  about  HIV  were
barriers to ART adherence elsewhere too (Irwin et al., 2003).
Understanding the cultural issues regarding adherence is an important aspect to  develop  evidence-based
interventions targeted at individuals with suboptimal adherence. Support  from  family  members,  including
children, medication reminders  and  disclosing  the  ART  status  to  others  (family  members,  peers,  and
society) had a positive  influence  on  adherence  [pic](Spire  et  al.,  2008b).  Governments  should
encourage a  supportive  environment  where  PLWHs  do  not  have  to  worry  about  stigma  and
discrimination, but talk openly to try  to  enhance  adherence.  This  review  argues  that  care  and
support, both emotional and medical, can help PLWHs to lead a fulfilling live.
Good relationships and trust with care providers are essential  to  build  open  communication  and
support for adherence. The review found that good relationships with their  care  provider  enabled
patient’s  to  have  better   information   about   the   importance   of   adhering   to   their   regimes
[pic](Starks et al., 2008), which is also fostered if patients  have  a  strong  relationship  with  their
health service provider (Lewis et al., 2006).
The  literature  supports  the  view  that  care  providers   spending   time   explaining   to   patients
encourages positivity and perhaps time spent talking to significant influencing groups  would  also
help to reinforce adherence [pic](Aspeling and van Wyk,  2008,  Coetzee  et  al.,  2004).    Service
providers  should  promote  optimal  adherence  by  giving  clear  instructions  about  taking   their
medication, medical follow-up, possible side-effects and  how  to  handle  the  side-effects  if  they
occur,  all  this  would  help  to  reinforce  adherence.  The  review  shows  that  acceptance,   open
communication, spending adequate time, cooperation and trust of health care  providers  enhanced
adherence [pic](Falagas et al., 2008, Ickovics and  Meade,  2002b,  Ickovics  and  Meade,  2002a).
Thus, the locus of responsibilities and commitments for adherence to  medication  shifts  from  the
individual ART-prescribed patient to the service providers and to treatment teams as a whole.
Conclusion
Adherence to ART is a  dynamic  phenomenon  that  varies  over  time  and  between  individuals.
Many factors negatively impacted  while  a  few  positively  on  adherence  to  ART  in  the  Asian
developing  communities.  Financial  difficulties,  stigma  and  discrimination,  simply  forgetting,
being too busy, concurrent substance abuse, and side-effects were identified as  factors  negatively
impacting on adherence. Similarly, self-efficacy, family supports  and  financial  assistances  were
reported as factors impacting positively on adherence and those should be promoted  to  the  wider
population.  Due  to  the  fear  of  exclusion  from  their   family   and   society,   patients   skipped
medication if they had to  take  it  in  front  of  others.  To  avoid  this,  patients  should  be  taught
strategies on how to handle taking pills in secret to increase adhere to their medication.  Similarly,
health care providers should give clear instructions and proper  counselling  to  the  patients  about
how to manage ART if side-effects occurr. Efforts must be made to understand  and  subsequently
develop targeted interventions (e.g. supporting with travel  costs,  better  access  points  for  repeat
prescription and consulting doctors for side-effects, improving relationship with care providers) to
promote and reinforce adherence.
Addressing the issue of non-adherence in  Asian  developing  countries  may  therefore  require  somewhat
different approaches to those practised in the developed countries or elsewhere.
This review did not perform a meta-analysis and simply enumerated the impacting factors because of
heterogeneity of  the  data  (mixed  studies).  Drawing  coherent  conclusions  in  this  review  was
hampered  by  limited  data  and  methodological   limitations   because   there   is   a   scarcity   of
comparative studies. It is as yet unclear whether the  behavioural,  educational,  bio-medical,  drug
treatments with fewer side-effects or financial supports are  more  or  less  powerful  in  enhancing
adherence. This needs to be assessed in future studies.  
Appendix I: Factors negatively impacting on adherence
|Reference/year      |Individual personal factors                                                                                  |
|                 |Simply forgot    |Being too    |Away from home              |Don’t understand   |Feeling depressed   |
|                 |                 |busy other   |                            |treatment          |                    |
|                 |                 |things       |                            |                   |                    |
|             |Stigma & discrimination                                                                                         |
 |Family support  |Self-efficacy |Willingness to live longer |Improved overall health |Getting financial assistance
|Higher income |Fear of drug resistance  |Use electronic reminder
                                                                                              |Obligation to live for family  |Good relationship with
providers  |Status disclosure  | |Akhila et al. 2010 | | | | | | | | | | | | |Kumarasamy et al. 2005 | | | | | | | | | | | | |Li
et al. 2010 |
                                      | | | | | | | | | | | |Ruanjahn et al. 2010 | | | | | | | | | | | | |Spire et al. 2008 | | | | | | | | | | |
| |Starks et al. 2008 | | | | | | | | | | | | |Total studies |4 |3 |3 |2 |2 |2 |2 |1 |1 |1 |1 | |
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